298 related articles for article (PubMed ID: 16297803)
1. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients.
Lepore JJ; Dec GW; Zapol WM; Bloch KD; Semigran MJ
J Heart Lung Transplant; 2005 Nov; 24(11):1950-6. PubMed ID: 16297803
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
[TBL] [Abstract][Full Text] [Related]
4. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
5. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
Foubert L; De Wolf D; Mareels K; Van Belleghem Y; Reyntjens K; Mortier E; Van Nooten G
Pediatr Res; 2002 Nov; 52(5):730-6. PubMed ID: 12409521
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients.
Rich GF; Murphy GD; Roos CM; Johns RA
Anesthesiology; 1993 Jun; 78(6):1028-35. PubMed ID: 8512095
[TBL] [Abstract][Full Text] [Related]
8. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
9. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
[TBL] [Abstract][Full Text] [Related]
12. Low doses of inhaled nitric oxide in heart transplant recipients.
Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Braun S; Schrötter H; Schmeisser A; Strasser RH
Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
[TBL] [Abstract][Full Text] [Related]
14. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
[TBL] [Abstract][Full Text] [Related]
15. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
Sablotzki A; Hentschel T; Hofmann S; Simm A; Mühling J; Czeslick E
J Clin Anesth; 2006 Mar; 18(2):108-13. PubMed ID: 16563327
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
17. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
[TBL] [Abstract][Full Text] [Related]
19. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]